https://www.selleckchem.com/pr....oducts/Trichostatin-
Overall, 35 patients were enrolled (30 with moderate and 5 with severe renal impairment). Most TEAEs were mild or moderate in severity; the most commonly reported were nasopharyngitis (22.9%) and somnolence (11.4%). Only 4 patients (11.4%) discontinued treatment due to TEAEs. Mirogabalin significantly decreased ADPS from baseline in patients with renal impairment; least squares mean change from baseline at Week 14 was -1.9 (95% confidence interval -2.8, -1.. Mirogabalin was well tolerated and significantly reduced pain levels w
Like
Comment
Share
